Skip to main content
. 2013 Jul 18;8(9):962–969. doi: 10.4161/epi.25696

Table 2. Distribution of subject’s characteristics by levels of biomarkers of AFB1 exposure.

Variable AFB1-albumin
 
Q1(n = 284) Q2(n = 289) Q3(n = 284) Q4(n = 282) p
Age, yrs
(Mean ± SD)
50.0 ± 9.8
50.2 ± 9.9
52.1 ± 8.8
52.0 ± 8.0
0.004
BMI, kg/m2 (Mean ± SD)
24.2 ± 2.9
24.0 ± 3.4
24.3 ± 3.4
23.9 ± 3.4
0.45
Gender
 
 
 
 
 
Female/Male
24/261
42/247
41/243
22/260
0.009
Smoking
 
 
 
 
 
No/Yes
155/130
158/129
154/130
136/146
0.33
Alcohol
 
 
 
 
 
No/Yes
229/54
247/42
225/59
224/57
0.20
HBsAg
 
 
 
 
 
Negative/Positive
217/68
127/162
168/116
174/108
< 0.0001
Anti-HCV
 
 
 
 
 
Negative/Positive
259/25
230/46
240/27
254/25
0.01
 
Urinary AFB1
 
Q1(n = 284)
Q2(n = 283)
Q3(n = 289)
Q4(n = 284)
 
Age, yrs
(Mean ± SD)
50.9 ± 9.6
51.2 ± 9.3
50.8 ± 8.6
51.3 ± 9.3
0.92
BMI, kg/m2 (Mean ± SD)
23.9 ± 3.1
24.2 ± 3.3
24.4 ± 3.3
23.8 ± 0.4
0.10
Gender
 
 
 
 
 
Female/Male
62/222
25/258
24/265
18/266
< 0.0001
Smoking
 
 
 
 
 
No/Yes
176/106
170/113
143/146
114/170
< 0.0001
Alcohol
 
 
 
 
 
No/Yes
241/42
236/46
233/56
215/68
0.03
HBsAg
 
 
 
 
 
Negative/Positive
163/121
183/100
172/117
168/116
0.32
Anti-HCV
 
 
 
 
 
Negative/Positive 228/42 249/26 259/22 247/33 0.03

One-way ANOVA test of the differences in the markers of AFB1 among groups.